- Clinical benefits of AcrySof® IQ PanOptix® Trifocal IOL for
patients and NGENUITY® 3D Visualization System for surgeons to be
presented
- Data to show the now widely available ARGOS® Biometer with
Image Guidance as a differentiated cataract planning
option
- COVID-19 practice resources available at the Alcon virtual
booth, in addition to the PanOptix symposium and Surgeon to Surgeon
presentations
Alcon, the global leader in eye care dedicated to helping people
see brilliantly, will present data that further supports
advancements in cataract surgery during the virtual American
Society of Cataract and Refractive Surgery (ASCRS) 2020 annual
meeting, taking place May 16-17. The company will also host a
virtual exhibit booth that will provide information on its latest
product innovations, including the AcrySof® IQ PanOptix® and ARGOS®
Biometer with Image Guidance, educational events and resources for
navigating the COVID-19 pandemic.
“While our primary focus right now continues to be supporting
surgeons with tools and resources needed during this unprecedented
time, we are proud to feature data and technologies to help foster
scientific exchange at this meeting,” said Sergio Duplan, Region
President, North America. “We hope highlighting relevant data on
our products, including PanOptix and the ARGOS Biometer, will be
beneficial to surgeons as they begin seeing patients again.”
Highlighting the Advantages of PanOptix, the First and Only
Trifocal Lens Available in the U.S.
Key data presented at this year’s ASCRS meeting continues to
demonstrate how PanOptix delivers an outstanding range of vision,
including study findings based on patient-reported outcomes that
indicate significant improvement in spectacle independence for
those using PanOptix.
PanOptix has now been evaluated by a broader share of the
ophthalmology community with data being presented at the meeting
that highlights key areas from rotational stability, quality of
vision, patient satisfaction to longer-term clinical data.
- Saturday, May 16
- Paper Presentation: The Panoptix Trifocal IOL: A Study of
Patient Satisfaction, Visual Disturbances, and Uncorrected Visual
Performance, Presented by Dr. John A. Hovanesian, et al. (7:45 AM –
7:50 AM ET).
- Paper Presentation: Evaluation of Quality of Vision and
Spectacle Independence with Bilateral Implantation of a Trifocal
Intraocular Lens, Presented by Dr. Andrew C. Shatz (1:05 PM - 1:10
PM ET).
- Paper Presentation: Evaluation of the Range of Vision with a
Novel Trifocal IOL, Presented by Dr. Jerry G. Hu. (1:45 PM – 1:50
PM ET).
- Paper Presentation: Objective and Subjective Assessment of
Vision Quality of a New Trifocal IOL, Presented by Dr. Jeffrey
Horn. (2:21 PM – 2:26 PM ET).
- Poster Presentation: Depth of Focus Evaluation of a New
Trifocal IOL, Presented by Dr. Bret L. Fisher. (Electronic poster
available on Saturday May 16, 2020).
- Poster Presentation: Early Clinical Experience with a New
Trifocal IOL, Presented by Dr. Elizabeth Yeu. (Electronic poster
available on Saturday May 16, 2020).
- Sunday, May 17
- Paper Presentation: Randomized Prospective Assessment of
Efficacy and Safety of a New Trifocal IOL, Presented by Dr. W.
Andrew Maxwell. (4:06 PM – 4:11 PM ET).
Alcon will also be hosting a symposium titled Steady As We Go:
PanOptix Trifocal IOL (presented via live stream) for existing or
interested PanOptix Trifocal IOL users. The symposium will be
moderated by Rosa Braga-Mele, MD who will host a discussion with
Quentin B. Allen, MD; Jeffrey D. Horn, MD; Farrell "Toby" Tyson, MD
and Elizabeth Yeu, MD. The event will be held Saturday, May 16
10:30 AM –11:30 AM, Virtual Meeting Room 3. To register, please
click HERE.
The ARGOS Biometer with Image Guidance Now Widely Available;
Competitive Benefits Highlighted
Combining MOVU’s swept source-OCT biometer with Alcon’s
image-guidance and vision planning software into an all-in-one
device, the new ARGOS Biometer with Image Guidance provides a
smarter1,2,3 surgical planning solution for surgeons, their staff
and their patients. Key benefits of the biometer include:
- Easier access to planning data with convenient, one-touch
software4,5;
- Better precision and high repeatability for accurate
measurements every time1,2,3 ; and
- Integration with the Alcon Cataract Refractive Suite for
greater efficiency.5
Data presented at the meeting will demonstrate the superiority
of the ARGOS Biometer with Image Guidance by Alcon against leading
biometers in various data presentations.6,7,8
- Saturday, May 16
- Paper Presentation: Optical Biometers: A Review of Published
Comparative Evidence, Presented by Dr. William B. Trattler, et al.
(12:10 PM – 12:15 PM ET).
- Paper Presentation: Axial Length Measurements Using
Component-Specific Indices of Refraction Versus a Composite Index:
Effect on IOL Power Calculation and Clinical Outcomes, Presented by
Dr. John Shammas. (12:23 PM – 12:28 PM ET).
- Poster Presentation: Efficiency and Economic Analysis of
Optical Biometers: Experience from a Private Eye Medical Center in
the United States of America, Presented by Dr. John Shammas, et al.
(Electronic poster available on Saturday May 16, 2020).
As many ophthalmologists begin the re-entry phase into cataract
surgery, there is no better time to consider the ARGOS Biometer for
a more efficient experience for surgeons, their staff and their
patients. “In our two studies that will be presented at ASCRS, we
will be highlighting new data looking at the improved efficiency of
the ARGOS Biometer and at the economic analysis of optical
biometers,” says Dr. John Shammas, Clinical Professor at the
University of Southern California (USC). These studies further
validate the importance of this new innovation.
NGENUITY 3D Visualization System® Improves Cataract Surgery
Outcomes
The NGENUITY 3D Visualization System continues to provide
surgeons with unprecedented visualization of the eye with greater
depth and detail during surgery than traditional microscopes.9 Key
data at the meeting will explore the benefits of implementing the
NGENUITY 3D digital visualization system in a high volume
ambulatory cataract surgery center, versus traditional operative
setups.
- Poster Presentation: Utilization and Integration of a 3D
Digital Visualization System for Use in High Volume Cataract
Surgery, Presented by Dr. Eric D. Rosenberg, et al. (Electronic
poster available on Saturday May 16, 2020).
Virtual, but still Networking: Resources for Supporting
Surgeons
Visit the Alcon booth to learn how the company is helping
communities during the pandemic. During the meeting, the Alcon
Foundation is hosting See the Good campaign (8:00 AM CT May 16
through 6:00 PM CT May 17) and will be donating $5 to World Central
Kitchen’s COVID-19 relief efforts, up to $10,000, for every caption
or photo submitted by attendees sharing the good they’ve seen or
done during this time.
Surgeon to Surgeon talks will also be taking place during the
meeting, giving attendees the opportunity to interact with other
surgeons about some of the most innovative eye care technologies in
the industry. Attendees can also visit the Medical Affairs section
of the virtual booth to learn more about CME and other medical
educational resources.
About ARGOS Biometer with Image
Guidance
ARGOS is a non-invasive, non-contact biometer based on
sweptsource optical coherence tomography (SS-OCT). The device is
intended to acquire ocular measurements as well as perform
calculations to determine the appropriate intraocular lens (IOL)
power and type for implantation during intraocular lens placement.
Please refer to the ARGOS® User Manual for a complete description
of proper use and maintenance, optical and technical
specifications, as well as a complete list of warnings and
precautions.
About AcrySof IQ PanOptix Trifocal
IOL
The AcrySof IQ PanOptix® Trifocal IOL is a type of multifocal
IOL used to focus images clearly onto the back of your eye (retina)
to allow clear vision after the cataract removal. In addition, the
center of the AcrySof IQ PanOptix® Trifocal IOL allows for better
near (reading) vision and intermediate (computer work) vision
versus what a monofocal lens would provide.
Potential Side Effects: Due to the design of multifocal IOLs,
there are some side effects that can be associated with the AcrySof
IQ PanOptix Trifocal IOL models. These may be worse than with a
monofocal IOL, including visual disturbances such as glare, rings
around lights, starbursts (rays around light sources), and reduced
contrast sensitivity (decrease in ability to distinguish objects
from their background, especially in dim lighting). These side
effects may make it more difficult to see while driving at night or
completing tasks in low lighting conditions such as at night or in
fog, or in a dimly lit room after surgery as compared to before
surgery.
Further, a toric IOL corrects astigmatism only when it is placed
in the correct position in the eye. There is a possibility that the
toric IOL could be placed incorrectly or could move within the eye.
If the toric lens is not positioned correctly following surgery,
the change in your astigmatism correction by the IOL, along with
any necessary correction with glasses, may cause visual
distortions. If the lens rotates in your eye, you may need
additional surgery to reposition or replace the IOL.
About NGENUITY 3D Visualization
System
The NGENUITY 3D Visualization System consists of a 3D
stereoscopic, high-definition digital video camera and workstation
to provide magnified stereoscopic images of objects during
micro-surgery. It acts as an adjunct to the surgical microscope
during surgery displaying real-time images or images from
recordings. Please refer to the User Manual for a complete list of
appropriate uses, warnings and precautions.
ABOUT ALCON
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, we offer the
broadest portfolio of products to enhance sight and improve
people’s lives. Our Surgical and Vision Care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. Our more than 20,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at www.alcon.com.
References
- Shammas HJ, Ortiz S, Shammas MC, Kim SH, Chong C. Biometry
measurements using a new large-coherence-length swept-source
optical coherence tomographer. J Cataract Refract Surg.
2016;42:50-61.
- Whang W, Yoo Y, Kang M, Joo C. Predictive accuracy of partial
coherence interferometry and swept-source optical coherence
tomography for intraocular lens power calculation. Sci Rep.
2018;8(1):13732.
- Shammas HJ. Accuracy of IOL power formulas with true axial
length versus simulated axial length measurement in 318 eyes using
an OCT biometer. 2019 ASCRS ASOA Annual Meeting. May 2019.
- VERION™ Reference Unit User Manual 2019.
- ARGOS® Biometer User Manual 2019.
- B. Trattler, et al. Optical Biometers: A Review of Published
Comparative Evidence. 2020 ASCRS Meeting. May 2020.
- Shammas, HJ. Axial Length Measurements Using Component-Specific
Indices of Refraction Versus a Composite Index: Effect on IOL Power
Calculation and Clinical Outcomes. 2020 ASCRS Meeting. May
2020
- Shammas, HJ, et al. Efficiency and Economic Analysis of Optical
Biometers: Experience from a Private Eye Medical Center in the
United States of America, Presented by Dr. John Shammas, et al.
2020 ASCRS Meeting. May 2020.
- Alcon Data on File. Yin L, Sarangapani R. Assessment of visual
attributes for NGENUITY® 3D Visualization System 1.0 for digitally
assisted vitreoretinal surgery. Alcon Modeling and Simulation.
December 2017.
Disclaimer
This press release contains
“forward-looking statements” within the meaning of the safe harbor
provisions of the United States Private Securities Litigation
Reform Act of 1995. Forward-looking statements can be identified by
words such as: “anticipate,” “intend,” “commitment,” “look
forward,” “maintain,” “plan,” “goal,” “seek,” “believe,” “project,”
“estimate,” “expect,” “strategy,” “future,” “likely,” “may,”
“should,” “will” and similar references to future periods.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties and risks that
are difficult to predict. Some of these factors are discussed in
our filings with the United States Securities and Exchange
Commission, including our Form 20-F. Should one or more of these
uncertainties or risks materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those anticipated. Therefore, you should not rely on any of
these forward-looking statements.
Forward-looking statements in this press release speak only as
of the date of its filing, and we assume no obligation to update
forward-looking statements as a result of new information, future
events or otherwise.
Connect with us on Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200511005778/en/
Investor Relations Christina
Cheng + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com
Media Relations Blake Overby
+ 817 551 4328 (Fort Worth) + 1 682 321 2897 (Fort Worth)
blake-1.overby@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Sep 2023 to Sep 2024